Vr Adviser, LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $414 Million distributed in 37 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Ocular Therapeutix, Inc with a value of $93.5M, Kal Vista Pharmaceuticals, Inc. with a value of $77.4M, Viridian Therapeutics, Inc.\De with a value of $52.3M, Pharvaris N.V. with a value of $48.9M, and Cogent Biosciences, Inc. with a value of $34M.
Examining the 13F form we can see an decrease of $192M in the current position value, from $606M to 414M.
Vr Adviser, LLC is based out at New York, NY
Below you can find more details about Vr Adviser, LLC portfolio as well as his latest detailed transactions.
